Stay updated on Diamyd® for Type 1 Diabetes Risk - Feasibility Clinical Trial
Sign up to get notified when there's something new on the Diamyd® for Type 1 Diabetes Risk - Feasibility Clinical Trial page.

Latest updates to the Diamyd® for Type 1 Diabetes Risk - Feasibility Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.8%

- Check28 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedA new site revision entry 'Revision: v3.7.0' was added to the record history. The previous revision entry 'Revision: v3.6.6' was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.6.6 was added to the study record history, replacing v3.6.5. This reflects a new internal revision of the record rather than changes to study details.SummaryDifference0.1%

Stay in the know with updates to Diamyd® for Type 1 Diabetes Risk - Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Diamyd® for Type 1 Diabetes Risk - Feasibility Clinical Trial page.